Evidence map›Paper›PMID 28828752›Full record

ArticleThe AAPS journal2017

Dibenzoylmethane Protects Against CCl4-Induced Acute Liver Injury by Activating Nrf2 via JNK, AMPK, and Calcium Signaling.

Mingnan Cao, Huixia Wang, Limei Guo, Simin Yang, Chun Liu, Tin Oo Khor, Siwang Yu, Ah-Ng Kong

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Linarin Protects Against CClDrug design, development and therapy · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. CClEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Mingnan CaoState Key Laboratory of Natural and Biomimetic Drugs; Department of Chemical Biology, Peking University School of Pharmaceutical Sciences, 38 Xueyuan Road, Haidian District, Beijing, 100191, People's Republic of China.
Huixia WangState Key Laboratory of Natural and Biomimetic Drugs; Department of Chemical Biology, Peking University School of Pharmaceutical Sciences, 38 Xueyuan Road, Haidian District, Beijing, 100191, People's Republic of China.
Limei GuoDepartment of Pathology, School of Basic Medical Sciences, Third Hospital, Peking University Health Science Center, Beijing, 100191, People's Republic of China.
Simin YangState Key Laboratory of Natural and Biomimetic Drugs; Department of Chemical Biology, Peking University School of Pharmaceutical Sciences, 38 Xueyuan Road, Haidian District, Beijing, 100191, People's Republic of China.
Chun LiuState Key Laboratory of Natural and Biomimetic Drugs; Department of Chemical Biology, Peking University School of Pharmaceutical Sciences, 38 Xueyuan Road, Haidian District, Beijing, 100191, People's Republic of China.
Tin Oo KhorDepartment of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Room 228 160 Frelinghuysen Road, Piscataway, NJ, 08854, USA.
Siwang YuState Key Laboratory of Natural and Biomimetic Drugs; Department of Chemical Biology, Peking University School of Pharmaceutical Sciences, 38 Xueyuan Road, Haidian District, Beijing, 100191, People's Republic of China. swang_yu@hsc.pku.edu.cn.
Ah-Ng KongDepartment of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Room 228 160 Frelinghuysen Road, Piscataway, NJ, 08854, USA. kongt@pharmacy.rutgers.edu.
State Key Laboratory of Natural and Biomimetic DrugsRutgers, The State University of New Jersey · USPeking University · CN

Funding

Epigenetic modifications by dietary PEITC in prostate cancerR01CA118947 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI KONG, AH-NG TONY · 2006 to 2015
$2.8M
Curcuma Longa: epigenetic effects in prostate and colon cancerR01AT007065 · NCCIH · RUTGERS, THE STATE UNIV OF N.J. · PI KONG, AH-NG TONY · 2012 to 2016
$2.3M
Prostate cancer prevention by tocopherolsR01CA152826 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI KONG, AH-NG TONY · 2011 to 2015
$1.6M
NCCIH NIH HHS R01 AT007065NCI NIH HHS R01 CA118947NCI NIH HHS R01 CA152826
6 · The paper itself

Abstract

Oxidative stress is an important pathogenic factor in various hepatic diseases. Nuclear factor-erythroid 2-related factor-2 (Nrf2), which coordinates the expression of an array of antioxidant and detoxifying genes, has been proposed as a potential target for prevention and treatment of liver disease. Dibenzoylmethane (DBM) is a minor ingredient in licorice that activates Nrf2 and prevents various cancers and oxidative damage. In the present study, the mechanisms by which DBM activates Nrf2 signaling were delineated, and its protective effect against carbon tetrachloride (CCl

Indexed as

AMP-Activated Protein KinasesAnimalsCalcium SignalingCarbon TetrachlorideCell Line, TumorChalconesChemical and Drug Induced Liver InjuryHeme Oxygenase-1HumansJNK Mitogen-Activated Protein KinasesKelch-Like ECH-Associated Protein 1MiceNF-E2-Related Factor 2AMP-Activated Protein KinasesCarbon TetrachlorideChalconesdibenzoylmethaneHeme Oxygenase-1JNK Mitogen-Activated Protein KinasesKeap1 protein, mouseKelch-Like ECH-Associated Protein 1Nfe2l2 protein, mouseNF-E2-Related Factor 2carbon tetrachloridedibenzoylmethaneHO-1liver injuryNrf2

Identifiers

PMID28828752
OpenAlexW2747260562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.